- Home
- BPMC vs FR Comparison
BPMC vs FR Comparison
Compare BPMC & FR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- FR
- Stock Information
- Founded
- BPMC 2008
- FR 1993
- Country
- BPMC United States
- FR United States
- Employees
- BPMC N/A
- FR N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- FR Real Estate Investment Trusts
- Sector
- BPMC Health Care
- FR Real Estate
- Exchange
- BPMC Nasdaq
- FR Nasdaq
- Market Cap
- BPMC 6.7B
- FR 6.6B
- IPO Year
- BPMC 2015
- FR 1994
- Fundamental
- Price
- BPMC $111.96
- FR $53.20
- Analyst Decision
- BPMC Buy
- FR Buy
- Analyst Count
- BPMC 19
- FR 12
- Target Price
- BPMC $122.72
- FR $57.83
- AVG Volume (30 Days)
- BPMC 789.4K
- FR 897.5K
- Earning Date
- BPMC 02-13-2025
- FR 02-05-2025
- Dividend Yield
- BPMC N/A
- FR 2.81%
- EPS Growth
- BPMC N/A
- FR 14.85
- EPS
- BPMC N/A
- FR 2.32
- Revenue
- BPMC $434,415,000.00
- FR $655,527,000.00
- Revenue This Year
- BPMC $108.09
- FR N/A
- Revenue Next Year
- BPMC $39.34
- FR $6.84
- P/E Ratio
- BPMC N/A
- FR $22.93
- Revenue Growth
- BPMC 100.93
- FR 8.51
- 52 Week Low
- BPMC $72.24
- FR $45.10
- 52 Week High
- BPMC $121.90
- FR $57.35
- Technical
- Relative Strength Index (RSI)
- BPMC 71.32
- FR 62.77
- Support Level
- BPMC $103.67
- FR $48.30
- Resistance Level
- BPMC $107.88
- FR $50.79
- Average True Range (ATR)
- BPMC 4.24
- FR 1.01
- MACD
- BPMC 2.43
- FR 0.40
- Stochastic Oscillator
- BPMC 97.93
- FR 98.20
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About FR First Industrial Realty Trust Inc.
First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. First Industrial's real estate portfolio is comprised of light industrial properties, which are split between industrial and office space, and bulk warehouse properties generally located in business parks near transportation hubs. While light industrial buildings represent a share of First Industrial's holdings, bulk warehouses make up the majority of its portfolio's square footage. The company derives the vast majority of its revenue from rental income tied to medium-term leases. First Industrial's customers include manufacturing, retail, wholesale trade, distribution, and professional services companies.